40
Zonaliz biotech raises $2.5M in first capital round
Company raise · Open-ended · PALO ALTO, CA · Form D filed 2026-10-05
Zonaliz, Inc., a Delaware-incorporated biotechnology company based in Palo Alto, has raised $2.5M from 2 investors under Regulation D exemption 6(b) with an indefinite offering size. The company filed its first Form D on October 5, 2026, following its initial sale on September 21, 2026.
Note: Company incorporated in 2026 and filed first Form D same year; indefinite offering amount means no hard cap disclosed.
First raise on EDGARoperating_company
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Gaoxian Chen | Director |
Signed by Gaoxian Chen, Director.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.